Advanced Micro Devices, Inc
—- Market cap
- —
- Debt
- +$4.10B
- Cash
- −$5.54B
Complete market value, debt and cash evidence is required for enterprise value.
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: AMD stock price vs DXC: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at DXC's multiple
Needs DXC P/E.
Implied fair value · at AMD's multiple
Needs AMD P/E.
Price unavailable
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Reported gross margin
Operating income + D&A
Lower is better
Not comparable
Lower leverage
Statements
Annual statements in reported currencies, with calculations and source evidence.
Values retain reported currencies and share bases. Select a figure to inspect its period, calculation and filing inputs. Differences require compatible units and periods.
Explore enterprise value and market valuation multiples in the valuation sections.
Trendline
Nine period-end years of reported revenue, earnings, and margins. Periods and currencies are shown with the data.
Price framework
USD market cap plus reported borrowing debt, less cash and equivalents. This EV proxy excludes investments, preferred stock and noncontrolling-interest adjustments.
Complete market value, debt and cash evidence is required for enterprise value.
Complete market value, debt and cash evidence is required for enterprise value.
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
ADVANCED MICRO DEVICES, INC · implied price per share
Bear
$39.12
Base
$45.31
Bull
$53.38
DXC TECHNOLOGY COMPANY · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Balance sheet health
Inspect reported liquidity and leverage alongside historical financial-health checks.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Cash excludes investments. EBITDA is an operating-income-plus-D&A proxy. Missing borrowing categories remain unavailable; select a value to inspect its inputs.
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
NVIDIA Corporation
AMD vs NVDA
Intel Corporation
AMD vs INTC
Broadcom Inc.
AMD vs AVGO
QUALCOMM Incorporated
AMD vs QCOM
Texas Instruments Incorporated
AMD vs TXN
Accenture plc
AMD vs ACN
INTERNATIONAL BUSINESS MACHINES CORP
AMD vs IBM
COGNIZANT TECHNOLOGY SOLUTIONS CORP
AMD vs CTSH
EPAM Systems, Inc.
AMD vs EPAM
Genpact LTD
AMD vs G
UNISYS CORP
AMD vs UIS
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
This explanation uses an earlier data snapshot or evidence version. Review its generation date and the current figures, or refresh after signing in.
If you believe AMD can sustain 34.3% revenue growth while defending 49.5% gross margin, then holding or buying can be justified because its operating quality is far superior to DXC; however, if growth normalizes or margins compress, the 182.4x P/E leaves substantial downside risk.
On a P/E basis, AMD’s implied price of $287.26 is 40.6% below the current price of $483.36, indicating the stock is priced well above a simple DXC-based multiple view. However, AMD’s premium is supported by far stronger growth, margins, and revenue scale than DXC.
Supporting Metrics